Keiya Uriu a, †
Equal contribution
, Yu Kaku a, †
Equal contribution
, Yoshifumi Uwamino d, Hiroshi Fujiwara e, Fumitake Saito f, The Genotype to Phenotype Japan (G2P-Japan) Consortium‡
Members listed in the appendix pp 6–7
Kei Sato
a, b, c, g, h, i, j a Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan
b International Research Center for Infectious Diseases, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan
c International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan
d Department of Laboratory Medicine, Keio University School of Medicine, Tokyo, Japan
e Fujiwara Clinic, Tokyo, Japan
f Namikibashi Clinic, Tokyo, Japan
g Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
h Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa, Japan
i Collaboration Unit for Infection, Joint Research Center for Human Retrovirus infection, Kumamoto University, Kumamoto, Japan
j MRC-University of Glasgow Centre for Virus Research, Glasgow, UK